|
所在平台: Coursera |
课程主页: https://www.coursera.org/learn/intellectual-property-healthcare-industry
课程评论：没有评论
课程名称：医疗行业的知识产权 课程概述：本课程首先介绍美国的一般知识产权法，然后分析这些法律背后的政策选择如何影响医疗行业主要参与者的行为。我们将探讨专利和商标如何影响制药公司，以及如何通过知识产权法解决涉及大学环境中的医学研究、遗传信息和材料所有权的复杂问题。课程最后通过国际制药公司、主要医疗设备公司以及新兴DNA测试行业的一家初创公司的深度案例研究进行总结。 课程大纲： 1. 现有美国知识产权保护： - 介绍知识产权概念和价值创造，学习美国主要的知识产权保护形式，包括版权、商标和专利，以及替代性知识产权保护方式。 2. 知识产权权利的哲学和经济理由： - 探讨为何需要知识产权保护，分析知识产权法对现代经济的影响及提供知识产权保护的政策原因。 3. 医疗行业的特殊知识产权规则： - 研究知识产权法如何创新性地响应现代医疗行业独特需求和特征。 4. 知识产权案例研究： - 深入分析三家主要医疗公司的知识产权策略：23andMe（基因测试公司）、诺华（制药公司）和美敦力（医疗设备公司）。
Name:Existing Intellectual Property Protection in the U.S.
Description:This module will introduce the concept of intellectual property and explain how it creates value. You will learn about the major forms of intellectual property protection in the United States - copyright, trademarks, and patents, as well as alternative forms of intellectual property protection.
Name:Philosophical and Economic Justifications of IP Rights
Description:Why have intellectual property protection at all? This module examines the effect of intellectual property law on the modern economy, and the policy reasons behind providing intellectual property protection.
Name:Special Intellectual Property Rules for Healthcare
Description:This module will explore the innovative ways in which intellectual property law has responded to the unique demands and features of the modern healthcare industry.
Name:Case Studies in Intellectual Property
Description:This module takes an in-depth look at the intellectual property strategies of three major healthcare companies: 23 and Me, Novartis, and Medtronic.
This course begins with an overview of general intellectual property law in the United States, then examines how the policy choices behind those laws shapes the behavior of major players in the healthcare industry. We will examine how patents and trademarks shape the behavior of pharmaceutical companies, and how complex issues involving medical research in university settings, and ownership of genetic information and material, are resolved by intellectual property laws. The course concludes with in-depth case studies of an international pharmaceutical company, a major medical device company, and a start-up in the emerging DNA-testing industry.
